Strides Pharma Science Ltd

NSE: STAR · BSE: 532531 · Pharmaceuticals & Biotechnology · 36 announcements

Share price: ₹999.40
Market cap: ₹9,212 Cr
Revenue (annual): ₹4,859 Cr
Net profit (annual): ₹556.2 Cr
P/E (TTM): 14.9×Sector 43.8×
Promoter holding: 29.00%+1.09% QoQ
FII holding: 27.98%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Results Update 1 Other Announcement 1 Management Change 1 Financial Results 1 Employee Stock Options 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

2 Nov 2026 16:39 IST BSE

Earnings Call

Strides Pharma Science Earnings Call Transcript: Key Takeaways

Record Q2 revenue ₹1,430 Cr (+17% YoY), Ex-US overtakes US, but EBITDA margin fell to 17.6% on input costs; US aspiration slips beyond FY28.

Open call summary → Read the filing ↗

29 Oct 2026 18:55 IST NSE

Earnings Call

Strides Pharma Science Investor Presentation: Key Takeaways

Q2FY27 revenue ₹14,297m (+17.1% YoY), EBITDA ₹2,509m (17.6% margin), reported PAT ₹1,341m (+2.0%). Ex-US revenue surpassed US for the first time; US ~$375m FY28 aspiration pushed beyond FY28.

Open call summary → Read the filing ↗